NO970020L - Immunmodulatorer - Google Patents

Immunmodulatorer

Info

Publication number
NO970020L
NO970020L NO970020A NO970020A NO970020L NO 970020 L NO970020 L NO 970020L NO 970020 A NO970020 A NO 970020A NO 970020 A NO970020 A NO 970020A NO 970020 L NO970020 L NO 970020L
Authority
NO
Norway
Prior art keywords
immunomodulators
Prior art date
Application number
NO970020A
Other languages
English (en)
Other versions
NO970020D0 (no
Inventor
Larsen Christian Groenhoej
Borbala Gesser
Original Assignee
Steeno Res Group As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steeno Res Group As filed Critical Steeno Res Group As
Publication of NO970020D0 publication Critical patent/NO970020D0/no
Publication of NO970020L publication Critical patent/NO970020L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO970020A 1994-07-05 1997-01-03 Immunmodulatorer NO970020L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK80094 1994-07-05
PCT/DK1995/000227 WO1996001318A1 (en) 1994-07-05 1995-06-07 Immunomodulators

Publications (2)

Publication Number Publication Date
NO970020D0 NO970020D0 (no) 1997-01-03
NO970020L true NO970020L (no) 1997-03-05

Family

ID=8097707

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970020A NO970020L (no) 1994-07-05 1997-01-03 Immunmodulatorer

Country Status (28)

Country Link
US (3) US6159937A (no)
EP (2) EP1013764A1 (no)
JP (1) JPH10502249A (no)
CN (1) CN1216992C (no)
AP (1) AP690A (no)
AT (1) ATE195003T1 (no)
AU (1) AU686816B2 (no)
BR (1) BR9508243A (no)
CA (1) CA2194444C (no)
CZ (1) CZ1497A3 (no)
DE (1) DE69518156T2 (no)
DK (1) DK0769054T3 (no)
EE (1) EE03451B1 (no)
ES (1) ES2148525T3 (no)
FI (1) FI970009A (no)
GR (1) GR3034628T3 (no)
HK (1) HK1012416A1 (no)
HU (1) HU220344B (no)
MX (1) MX9606537A (no)
NO (1) NO970020L (no)
NZ (1) NZ287406A (no)
PL (1) PL181042B1 (no)
PT (1) PT769054E (no)
RO (1) RO118758B1 (no)
RU (1) RU2218348C2 (no)
SK (1) SK283096B6 (no)
UA (1) UA57702C2 (no)
WO (1) WO1996001318A1 (no)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) 1995-03-24 1995-03-24 Astra Ab New peptides
WO1997026278A1 (en) * 1996-01-18 1997-07-24 Steeno Research Group A/S Synthetic il-10 analogues
US20030124125A1 (en) * 1996-04-05 2003-07-03 South Alabama Medical Science Foundation Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
NZ332412A (en) * 1996-05-02 2000-05-26 Schering Corp use of interleuklin-10 for treating or preventing ischemia-reperfusion injury
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
US6086868A (en) * 1997-04-30 2000-07-11 Schering Corporation Method for treating or preventing ischemia-reperfusion injury
CA2316296A1 (en) * 1997-10-10 1999-04-22 Imperial College Of Science, Technology And Medicine Use of csaidtm compounds for the management of uterine contractions
WO2000037096A2 (en) * 1998-12-22 2000-06-29 Schering Corporation Treatment of hepatitis c virus infections with interleukin-10
JP2003500419A (ja) * 1999-05-25 2003-01-07 カンジ，インコーポレイテッド 肺疾患の遺伝子治療
CA2429769C (en) * 2000-12-07 2016-04-26 Board Of Regents, The University Of Texas System Methods of treatment involving human mda-7
WO2002057283A1 (en) * 2001-01-19 2002-07-25 Baylor College Of Medecine Methods and compositions in breast cancer diagnosis and therapeutics
US20040086896A1 (en) * 2001-04-19 2004-05-06 Julie Carman Polynucleotides and polypeptides associated with the NF-kB pathway
WO2003068152A2 (en) * 2002-02-11 2003-08-21 Arkion Life Sciences Llc Purified cytokine inhibitory factor
JP2005533000A (ja) * 2002-03-05 2005-11-04 ボード　オブ　リージェンツ，　ザ　ユニバーシティ　オブ　テキサス　システム Ｍｄａ−７に関与する免疫誘導を増強する方法
EP1444989A1 (en) * 2003-02-07 2004-08-11 Giorgio Dr. Stassi Sensitizing cells for apoptosis by selectively blocking cytokines
ES2522525T3 (es) * 2003-05-15 2014-11-14 Genentech, Inc. Métodos y composiciones para la prevención y el tratamiento de la sepsis
US7261882B2 (en) 2003-06-23 2007-08-28 Reagents Of The University Of Colorado Methods for treating neuropathic pain by administering IL-10 polypeptides
US20050164244A1 (en) * 2003-10-23 2005-07-28 David Glass Methods of determining juvenile arthritis classification
WO2005082396A2 (en) * 2003-12-01 2005-09-09 Introgen Therapeutics, Inc. Use of mda-7 to inhibit infection by pathogenic organisms
WO2005087793A2 (en) * 2004-02-05 2005-09-22 The Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Immunostimulatory compositions and uses thereof
US20070281041A1 (en) * 2004-03-02 2007-12-06 Introgen Therapeutics, Inc. Compositions and Methods Involving MDA-7 for the Treatment of Cancer
WO2006063028A2 (en) * 2004-12-07 2006-06-15 The Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Immunostimulatory compositions and uses thereof
GB0500643D0 (en) * 2005-01-13 2005-02-23 Renovo Ltd Medicaments
JP2008531481A (ja) * 2005-02-08 2008-08-14 ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム 癌の治療のための、ｍｄａ−７を含む組成物および方法
US20100028296A1 (en) * 2005-05-02 2010-02-04 Chavez Raymond A Use of cytokine-derived peptides in treatment of pain and neurodegenerative disease
US8114964B2 (en) * 2005-05-19 2012-02-14 Centocor, Inc. Anti-MCP-1 antibodies, compositions, methods and uses
PT2816118T (pt) 2005-05-31 2018-11-28 Univ Colorado Regents Métodos para administração de genes
EP2041576B1 (en) * 2006-06-21 2011-08-10 Apogenix GmbH Differential cytokine expression in human cancer
AU2007271349A1 (en) * 2006-07-06 2008-01-10 Apogenix Gmbh Human IL-4 muteins in combination with chemotherapeutics or pro-apoptotic agents in cancer therapy
US7838497B2 (en) * 2006-12-13 2010-11-23 Susavion Biosciences, Inc. Pro-angiogenic peptides
USRE46425E1 (en) 2006-12-13 2017-06-06 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
US8460697B2 (en) * 2006-12-13 2013-06-11 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
CN101391103B (zh) * 2008-07-31 2013-07-24 张可 一种预防和治疗艾滋病病毒感染的药物组合物
WO2010022227A1 (en) * 2008-08-20 2010-02-25 Schering Corporation Methods for monitoring il-10 therapy
US8513185B2 (en) 2009-10-13 2013-08-20 Alexander B. Sigalov Inhibition of TREM receptor signaling with peptide variants
KR20140012127A (ko) * 2011-03-14 2014-01-29 세로두스 에이에스에이 인터류킨-1 수용체의 길항제
EP2814843B1 (en) 2012-02-13 2020-03-18 Agency For Science, Technology And Research IL-ß NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES
SI3021873T1 (sl) 2013-07-18 2018-12-31 Xalud Therapeutics, Inc. Sestavek za zdravljenje vnetne sklepne bolezni
JP6140566B2 (ja) * 2013-07-31 2017-05-31 アイシン・エィ・ダブリュ株式会社 コイル装着方法及びコイル装着治具
CN105944086B (zh) * 2016-06-13 2017-08-25 浙江生创精准医疗科技有限公司 Il‑8单独或与其他细胞因子联合在治疗肝纤维化中的用途
EP3551046B1 (en) 2016-12-07 2023-07-19 Biora Therapeutics, Inc. Gastrointestinal tract detection methods, devices and systems
WO2018183931A1 (en) 2017-03-30 2018-10-04 Progenity Inc. Treatment of a disease of the gastrointestinal tract with il-10 or an il-10 agonist
EP3883634A1 (en) 2018-11-19 2021-09-29 Progenity, Inc. Methods and devices for treating a disease with biotherapeutics
CN113711038A (zh) * 2019-01-31 2021-11-26 积水医疗株式会社 用于生物样品中游离aim的免疫分析方法及用于检测对象中nash的方法
CN115666704A (zh) 2019-12-13 2023-01-31 比奥拉治疗股份有限公司 用于将治疗剂递送至胃肠道的可摄取装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
ES2138976T3 (es) * 1991-08-06 2000-02-01 Schering Corp Uso de analogos o antagonistas de interleucina-10 para tratar la toxicidad inducida por endotoxinas o superantigenos.
AU679908B2 (en) * 1992-03-04 1997-07-17 Schering Corporation Use of interleukin-10 to suppress graft-vs.-host disease
CA2085291A1 (en) * 1992-07-30 1994-01-31 Martin L. Breitman Novel receptor tyrosine kinase
KR0170037B1 (ko) * 1992-08-20 1999-02-01 에릭 에스. 딕커 인터루킨-4 및/또는 인터루킨-10을 함유하는 약제학적 조성물
EP0711346A1 (en) * 1993-07-26 1996-05-15 Schering Corporation Agonists and antagonists of human interleukin-10

Also Published As

Publication number Publication date
AP9700962A0 (en) 1997-04-30
DK0769054T3 (da) 2000-11-13
EP1013764A1 (en) 2000-06-28
JPH10502249A (ja) 1998-03-03
HU9603615D0 (en) 1997-02-28
DE69518156D1 (de) 2000-08-31
SK283096B6 (sk) 2003-02-04
PL319429A1 (en) 1997-08-04
DE69518156T2 (de) 2001-01-11
AU686816B2 (en) 1998-02-12
EE03451B1 (et) 2001-06-15
CZ1497A3 (en) 1997-05-14
SK161496A3 (en) 1997-08-06
RO118758B1 (ro) 2003-10-30
FI970009A0 (fi) 1997-01-02
US6599501B1 (en) 2003-07-29
HUT76673A (en) 1997-10-28
UA57702C2 (uk) 2003-07-15
ATE195003T1 (de) 2000-08-15
RU2218348C2 (ru) 2003-12-10
CA2194444C (en) 2003-01-14
NZ287406A (en) 1998-07-28
CN1216992C (zh) 2005-08-31
GR3034628T3 (en) 2001-01-31
US6168791B1 (en) 2001-01-02
EP0769054B1 (en) 2000-07-26
NO970020D0 (no) 1997-01-03
PL181042B1 (pl) 2001-05-31
WO1996001318A1 (en) 1996-01-18
HU220344B (hu) 2001-12-28
PT769054E (pt) 2000-11-30
AU2612195A (en) 1996-01-25
EE9700029A (et) 1997-08-15
ES2148525T3 (es) 2000-10-16
CA2194444A1 (en) 1996-01-18
BR9508243A (pt) 1997-10-21
CN1159830A (zh) 1997-09-17
EP0769054A1 (en) 1997-04-23
HK1012416A1 (en) 1999-07-30
US6159937A (en) 2000-12-12
AP690A (en) 1998-10-16
MX9606537A (es) 1997-12-31
FI970009A (fi) 1997-03-04

Similar Documents

Publication Publication Date Title
DE69518156D1 (de) Immunomodulatoren
ATA147195A (de) Alkoxyphenyl-substituierte bisbenzoylphosphinoxide
BR9507091A (pt) Combinações insecticidamente ativas
ATA108995A (de) Differenzdruckakkumulator
DE69507478D1 (de) Anti-gleitmittel
NO950169D0 (no) Undervannsfartöy
ATA11894A (de) Stauförderbahn
BR7400683U (pt) Odontoportátil
BR7401742U (pt) Sub-capacete
BR7400865U (pt) Multi-arremate
BR7401967U (pt) Vassoura-mangueira
BR9400290A (pt) Selo-contrato
BR9401008A (pt) Helistato
BR9402584A (pt) Chavecheque
BR9403310A (pt) Regulex
BR7402342U (pt) Hidro-potenciômetro
BR9403758A (pt) Multiplic
BR9403309A (pt) Choppometro
BR7401734U (pt) Termometro-caneta
BR7401146U (pt) Translixo
BR9401264A (pt) Prevgás
BR9401864A (pt) Pescoço-giratório
BR7401141U (pt) PortA-espoNja
BR7400879U (pt) Boxboy
BR9403759A (pt) Mastercalc

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application